Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PRIYA SIVARAMAN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1952398588
CMS profile
43730
Location
WAYNE, NJ

General Payments · PY2018–2024

$2,395.57

  • Reported across 130 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$696.40

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $627.41 34
Education $68.99 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $140.88 8
Novo Nordisk AS $120.50 7
Astellas Pharma US Inc $116.10 3
Medtronic, Inc. $66.09 2
Amgen Inc. $62.59 4
GlaxoSmithKline, LLC. $52.23 3
PFIZER INC. $48.66 3
Abbott Laboratories $37.96 2
Lilly USA, LLC $18.94 1
Otsuka America Pharmaceutical, Inc. $18.46 1
ABBVIE INC. $13.99 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $337.58 15
PY2019 $497.76 28
PY2020 $37.06 3
PY2022 $203.42 13
PY2023 $623.35 36
PY2024 $696.40 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $16.29 02/08/2024 Food and Beverage Undisputed 01/23/2026 1125354135 CMS
Abbott Laboratories $21.67 05/10/2024 Food and Beverage Undisputed 01/23/2026 1125354137 CMS
ABBVIE INC. $13.99 05/14/2024 Food and Beverage Undisputed 01/23/2026 1106116177 CMS
Amgen Inc. $14.82 02/20/2024 Food and Beverage Undisputed 01/23/2026 1117686012 CMS
Amgen Inc. $15.27 03/19/2024 Food and Beverage Undisputed 01/23/2026 1117686014 CMS
Amgen Inc. $15.88 05/21/2024 Food and Beverage Undisputed 01/23/2026 1117686016 CMS
Amgen Inc. $16.62 11/19/2024 Food and Beverage Undisputed 01/23/2026 1117686018 CMS
Astellas Pharma US Inc $27.58 06/04/2024 Food and Beverage Undisputed 01/23/2026 1139353501 CMS
Astellas Pharma US Inc $68.99 09/24/2024 Education Undisputed 01/23/2026 1139408695 CMS
Astellas Pharma US Inc $19.53 10/01/2024 Food and Beverage Undisputed 01/23/2026 1139398593 CMS
GlaxoSmithKline, LLC. $16.01 03/06/2024 Food and Beverage Undisputed 01/23/2026 1116370367 CMS
GlaxoSmithKline, LLC. $16.87 07/02/2024 Food and Beverage Undisputed 01/23/2026 1116400222 CMS
GlaxoSmithKline, LLC. $19.35 11/18/2024 Food and Beverage Undisputed 01/23/2026 1116119549 CMS
Lilly USA, LLC $18.94 08/19/2024 Food and Beverage Undisputed 01/23/2026 1135303267 CMS
Medtronic, Inc. $31.36 02/17/2024 Food and Beverage Undisputed 01/23/2026 1119563208 CMS
Medtronic, Inc. $34.73 10/31/2024 Food and Beverage Undisputed 01/23/2026 1119563210 CMS
Novartis Pharmaceuticals Corporation $14.40 01/19/2024 Food and Beverage Undisputed 01/23/2026 1087198799 CMS
Novartis Pharmaceuticals Corporation $20.64 02/08/2024 Food and Beverage Undisputed 01/23/2026 1087198801 CMS
Novartis Pharmaceuticals Corporation $13.90 02/22/2024 Food and Beverage Undisputed 01/23/2026 1087198811 CMS
Novartis Pharmaceuticals Corporation $23.00 03/15/2024 Food and Beverage Undisputed 01/23/2026 1087198809 CMS
Novartis Pharmaceuticals Corporation $18.21 04/18/2024 Food and Beverage Undisputed 01/23/2026 1087198817 CMS
Novartis Pharmaceuticals Corporation $14.64 05/10/2024 Food and Beverage Undisputed 01/23/2026 1087198819 CMS
Novartis Pharmaceuticals Corporation $15.63 07/11/2024 Food and Beverage Undisputed 01/23/2026 1087198829 CMS
Novartis Pharmaceuticals Corporation $20.46 10/31/2024 Food and Beverage Undisputed 01/23/2026 1087198851 CMS
Novo Nordisk Inc $14.81 03/11/2024 Food and Beverage Undisputed 01/23/2026 1097513595 CMS
Novo Nordisk Inc $16.44 03/14/2024 Food and Beverage Undisputed 01/23/2026 1096874338 CMS
Novo Nordisk Inc $15.83 04/11/2024 Food and Beverage Undisputed 01/23/2026 1096918178 CMS
Novo Nordisk Inc $16.51 05/16/2024 Food and Beverage Undisputed 01/23/2026 1097213503 CMS
Novo Nordisk Inc $19.56 08/05/2024 Food and Beverage Undisputed 01/23/2026 1097558743 CMS
Novo Nordisk Inc $19.05 09/23/2024 Food and Beverage Undisputed 01/23/2026 1097656236 CMS
Novo Nordisk Inc $18.30 11/04/2024 Food and Beverage Undisputed 01/23/2026 1097365707 CMS
Otsuka America Pharmaceutical, Inc. $18.46 10/04/2024 Food and Beverage Undisputed 01/23/2026 1118984252 CMS
PFIZER INC. $15.65 03/08/2024 Food and Beverage Undisputed 01/23/2026 1131221316 CMS
PFIZER INC. $16.89 05/04/2024 Food and Beverage Undisputed 01/23/2026 1131399026 CMS
PFIZER INC. $16.12 06/11/2024 Food and Beverage Undisputed 01/23/2026 1131658789 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.